Catalog No.:AA01EO9J

863513-93-3 | Cebranopadol ((1α,4α)stereoisomer)

Name: Name:Cebranopadol ((1α,4α)stereoisomer)
Brand: AABLOCKS
SKU: AA01EO9J
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

2mg

95%

1 week

$352.00 $247.00

- +

5mg

95%

1 week

$606.00 $424.00

- +

Technical Information
Properties
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Literature

Technical Information

Catalog Number:

AA01EO9J

Chemical Name:

Cebranopadol ((1α,4α)stereoisomer)

CAS Number:

863513-93-3

Molecular Formula:

C24H27FN2O

Molecular Weight:

378.4824

MDL Number:

MFCD28386279

SMILES:

Fc1ccc2c(c1)c1CCO[C@@]3(c1[nH]2)CC[C@](CC3)(N(C)C)c1ccccc1

Properties

Computed Properties

Complexity:

553

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

XLogP3:

4.3

Literature

Title: Cebranopadol: a first in-class example of a nociceptin/orphanin FQ receptor and opioid receptor agonist.

Journal: British journal of anaesthesia 20150301

Title: Discovery of a Potent Analgesic NOP and Opioid Receptor Agonist: Cebranopadol.

Journal: ACS medicinal chemistry letters 20140814

Title: Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist.

Journal: The Journal of pharmacology and experimental therapeutics 20140601

Title: Schunk S, et al. Discovery of a Potent Analgesic NOP and Opioid Receptor Agonist: Cebranopadol. ACS Med Chem Lett. 2014 Jun 24;5(8):857-62

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS

Related Products of 863513-93-3

863513-92-2

Building Blocks

More >

1415390-47-4 | (R)-BPO-27 | AA01EOFV | MFCD30532675

1370046-40-4 | SSE15206 | AA01EOLP | MFCD31746881

1394157-34-6 | Sofosbuvir impurity N | AA01EOPY | MFCD28386721

286834-86-4 | α-methyl-7-benzofuranethanamine,monohydrochloride | AA01EOZ2

958293-77-1 | 6-methoxy-α-(methyl-d3)-2-naphthaleneaceticacid | AA01EPAA | MFCD09841073

1400742-48-4 | 1-[(tetrahydro-2H-pyran-4-yl)methyl]-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide | AA01EPHT

104071-84-3 | 5,14-dioxo-9,10-dithia-2,6,13,17-tetraazaoctadecanedioicacid,1,18-bis(phenylmethyl)ester | AA01EPN0

1987882-62-1 | (2S)-25-cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)-avermectinA1a | AA01EPTN

261155-87-7 | N-[(1S,2R,3E)-1-[[(O-α-D-galactopyranosyl-(1→4)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecenbr-1-yl]-tricyclo[3.3.1.13,7]decane-1-acetamide | AA01EQ34

2183239-01-0 | 7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline-7,7,9,9-d4 | AA01EQ9I

Tags:863513-93-3 Molecular Formula|863513-93-3 MDL|863513-93-3 SMILES|863513-93-3 Cebranopadol ((1α,4α)stereoisomer)